These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 27994729)

  • 61. Mitogen-activated protein kinase activation during IgG-dependent phagocytosis in human neutrophils: inhibition by ceramide.
    Suchard SJ; Mansfield PJ; Boxer LA; Shayman JA
    J Immunol; 1997 May; 158(10):4961-7. PubMed ID: 9144515
    [TBL] [Abstract][Full Text] [Related]  

  • 62. A single amino acid substitution makes ERK2 susceptible to pyridinyl imidazole inhibitors of p38 MAP kinase.
    Fox T; Coll JT; Xie X; Ford PJ; Germann UA; Porter MD; Pazhanisamy S; Fleming MA; Galullo V; Su MS; Wilson KP
    Protein Sci; 1998 Nov; 7(11):2249-55. PubMed ID: 9827991
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Obligate mitogen-activated protein kinase activation in parathyroid hormone stimulation of calcium transport but not calcium signaling.
    Sneddon WB; Liu F; Gesek FA; Friedman PA
    Endocrinology; 2000 Nov; 141(11):4185-93. PubMed ID: 11089552
    [TBL] [Abstract][Full Text] [Related]  

  • 64. ERK2 mediates oxytocin-stimulated PGE2 synthesis.
    Strakova Z; Copland JA; Lolait SJ; Soloff MS
    Am J Physiol; 1998 Apr; 274(4):E634-41. PubMed ID: 9575824
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The RAF-MEK-ERK pathway: targeting ERK to overcome obstacles to effective cancer therapy.
    Yu Z; Ye S; Hu G; Lv M; Tu Z; Zhou K; Li Q
    Future Med Chem; 2015; 7(3):269-89. PubMed ID: 25826360
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Macrocyclic Inhibitors of ERK2 Kinase.
    Rosse G
    ACS Med Chem Lett; 2016 Dec; 7(12):1020-1021. PubMed ID: 27994729
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 4.